FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: December 31, 2014 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person * Batton Thomas Henry Jr (Last) (First) (Middle) C/O TENON MEDICAL, INC. 104 COOPER CT. (Street) LOS GATOS CA 95032 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 10/01/2026	3. Issuer Name and Ticker or Trading Symbol Tenon Medical, Inc. [ TNON ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Revenue Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (1)	(2)	(2)	Common Stock	10,000	(1)	D

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs") under the Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended, upon the Reporting Person's appointment to serve as a Chief Revenue Officer of the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share, upon vesting.

2. The RSUs vest over three years, with one-third vesting on October 1, 2027 and the remaining two-thirds vesting in four equal semi-annual installments thereafter, subject to the Reporting Person's continued service. The RSUs do not have an expiration date.

	/s/ Thomas Batton Jr.	10/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.